4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial by Hoskin, Peter J, Prof, Kirkwood, Amy A, MSc, Popova, Bilyana, MSc, Smith, Paul, MSc, Robinson, Martin, FRCR, Gallop-Evans, Eve, FRCR, Coltart, Stewart, FRCR, Illidge, Timothy, Prof, Madhavan, Krishnaswamy, FRCR, Brammer, Caroline, FRCR, Diez, Patricia, MSc, Jack, Andrew, Prof, Syndikus, Isabel, FRCR

Get full text

Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study by Ng, Quan-Sing, MRCP, Goh, Vicky, FRCR, Milner, Jessica, BSc, Stratford, Michael R, PhD, Folkes, Lisa K, BSc, Tozer, Gillian M, Prof, Saunders, Michele I, Prof, Hoskin, Peter J, Prof

Get full text

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespe... by Hoskin, Peter, Prof, Sartor, Oliver, Prof, O'Sullivan, Joe M, Prof, Johannessen, Dag Clement, MD, Helle, Svein I, MD, Logue, John, FRCR, Bottomley, David, FRCR, Nilsson, Sten, Prof, Vogelzang, Nicholas J, Prof, Fang, Fang, PhD, Wahba, Mona, MD, Aksnes, Anne-Kirsti, PhD, Parker, Christopher, MD

Get full text

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, rand... by Sartor, Oliver, Prof, Coleman, Robert, Prof, Nilsson, Sten, Prof, Heinrich, Daniel, MD, Helle, Svein I, MD, O'Sullivan, Joe M, Prof, Fosså, Sophie D, Prof, Chodacki, Aleš, MD, Wiechno, Paweł, MD, Logue, John, FRCR, Widmark, Anders, Prof, Johannessen, Dag Clement, MD, Hoskin, Peter, Prof, James, Nicholas D, Prof, Solberg, Arne, MD, Syndikus, Isabel, FRCR, Vogelzang, Nicholas J, Prof, O'Bryan-Tear, C Gillies, MRCP, Shan, Minghua, PhD, Bruland, Øyvind S, Prof, Parker, Christopher, MD

Get full text

Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial by Chow, Edward, Dr Prof, van der Linden, Yvette M, MD, Roos, Daniel, Prof, Hartsell, William F, MD, Hoskin, Peter, Prof, Wu, Jackson S Y, MD, Brundage, Michael D, Prof, Nabid, Abdenour, MD, Tissing-Tan, Caroline J A, MD, Oei, Bing, MD, Babington, Scott, MBChB, Demas, William F, Prof, Wilson, Carolyn F, MSc, Meyer, Ralph M, Prof, Chen, Bingshu E, PhD, Wong, Rebecca K S, Prof

Get full text

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial by James, Nicholas D, Prof, Sydes, Matthew R, CSci, Mason, Malcolm D, Prof, Clarke, Noel W, Prof, Anderson, John, MD, Dearnaley, David P, Prof, Dwyer, John, FRIC, Jovic, Gordana, PhD, Ritchie, Alastair WS, FRCSEd, Russell, J Martin, FRCR, Sanders, Karen, BSc, Thalmann, George N, Prof, Bertelli, Gianfilippo, MD, Birtle, Alison J, FRCR, O'Sullivan, Joe M, Prof, Protheroe, Andrew, PhD, Sheehan, Denise, FRCR, Srihari, Narayanan, FRCR, Parmar, Mahesh KB, Prof

Get full text